(JAZZ) Jazz Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Jazz Pharmaceuticals | (JAZZ) share price targets
Complete technical analysis of Jazz Pharmaceuticals (JAZZ) by charts plus indicators, forecast predictions and share price targets for Jazz Pharmaceuticals (JAZZ)
Jazz Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2025-12-09 View latest technical analysis
10 day averaged volume of Jazz Pharmaceuticals is 1094470
| Date | Daily Closing Price | Open | High | Low | Volume |
| 09 Tue Dec 2025 | 162.26 | 168.78 | 170.05 | 161.83 | 1.075 times |
| 08 Mon Dec 2025 | 168.94 | 169.92 | 170.87 | 168.47 | 0.791 times |
| 05 Fri Dec 2025 | 169.70 | 168.63 | 171.51 | 167.35 | 0.832 times |
| 04 Thu Dec 2025 | 166.91 | 166.38 | 167.30 | 164.44 | 0.772 times |
| 03 Wed Dec 2025 | 167.10 | 166.98 | 169.25 | 166.09 | 0.855 times |
| 02 Tue Dec 2025 | 166.71 | 173.07 | 173.60 | 166.54 | 1.327 times |
| 01 Mon Dec 2025 | 172.12 | 174.23 | 175.55 | 170.57 | 1.393 times |
| 28 Fri Nov 2025 | 176.53 | 176.53 | 177.70 | 175.06 | 0.302 times |
| 26 Wed Nov 2025 | 176.92 | 181.61 | 181.61 | 176.66 | 0.831 times |
| 25 Tue Nov 2025 | 180.05 | 181.24 | 182.75 | 178.01 | 1.03 times |
My analysis of stock is bearish for shortterm, and stock might move down till 151.8 or till 134.4. Use a stoploss of 166.2 and if the stock hits stoploss, then it can shoot up till 180.64
Share price targets for Jazz Pharmaceuticals (JAZZ)
| Target Type | Value |
| Downside Target | 105.00 |
| Downside Target | 123.88 |
| Downside Target | 128.13 |
| Downside Target | 131.76 |
| Downside Target | 140.39 |
| Downside Target | 161.83 |
| Upside Target | 170.87 |
| Upside Target | 172.19 |
| Upside Target | 175.55 |
| Upside Target | 182.75 |
| Upside Target | 182.99 |
Intraday share price targets for Jazz Pharmaceuticals (JAZZ)
| Target Type | Value |
| Downside Intraday Target | 159.1 |
| Downside Intraday Target | 155.95 |
| Upside Intraday Target | 168.14 |
| Upside Intraday Target | 174.03 |
| Upside Intraday Target | 164.99 |
Weekly technical analysis of Jazz Pharmaceuticals (JAZZ)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 09 Tue Dec 2025 | 162.26 | 169.92 | 170.87 | 161.83 | 0.36 times |
| 05 Fri Dec 2025 | 169.70 | 174.23 | 175.55 | 164.44 | 1.285 times |
| 28 Fri Nov 2025 | 176.53 | 174.89 | 182.75 | 172.19 | 0.32 times |
| 21 Fri Nov 2025 | 176.93 | 168.00 | 182.99 | 162.60 | 2.712 times |
| 14 Fri Nov 2025 | 141.07 | 133.44 | 142.84 | 132.10 | 1.397 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Jazz Pharmaceuticals (JAZZ)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 09 Tue Dec 2025 | 162.26 | 174.23 | 175.55 | 161.83 | 0.287 times |
| 28 Fri Nov 2025 | 176.53 | 136.55 | 182.99 | 128.80 | 1.771 times |
| 31 Fri Oct 2025 | 137.64 | 131.78 | 140.39 | 131.76 | 1.017 times |
| 30 Tue Sep 2025 | 131.80 | 127.23 | 133.00 | 123.88 | 0.795 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Jazz Pharmaceuticals (JAZZ)
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Jazz Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Jazz Pharmaceuticals in short term but the sell signal is initial and weak.
Jazz Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Jazz Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Jazz Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 170.26 and Jazz Pharmaceuticals (JAZZ) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Jazz Pharmaceuticals (JAZZ) stock. Volume based technical analysis of Jazz Pharmaceuticals (JAZZ) stock is negative.
Jazz Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Jazz Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Jazz Pharmaceuticals in short term but the sell signal is initial and weak.
Jazz Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Jazz Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Jazz Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 170.26 and Jazz Pharmaceuticals (JAZZ) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Jazz Pharmaceuticals (JAZZ) stock. Volume based technical analysis of Jazz Pharmaceuticals (JAZZ) stock is negative.
Jazz Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.